Apollo and Anjac announce closing of arrangement

TORONTO – (COMMERCIAL THREAD) – Apollo Healthcare Corp. (TSX: AHC, OTCQX: AHCCF) (“Apollo“or the”Society“) And Anjac SAS (“Anjac“) are pleased to announce that they have completed the previously announced plan of arrangement (the”Arrangement“) Under section 182 of the Business Corporations Act (Ontario) (“OBCA“) between Apollo, Anjac and 1000009701 Ontario Inc. (the”Buyer“), by virtue of which, among other things, the purchaser has acquired all of the issued and outstanding Class B shares of Apollo (“Apollo Actions”) Other than certain Apollo Shares held by Charles Wachsberg and Richard Wachsberg.

Following the overwhelming support of Apollo stock holders (“Shareholders”) Approving the Arrangement at a special meeting held on December 24, 2021, the Ontario Superior Court of Justice (Commercial List) approved the Arrangement on January 4, 2021. Pursuant to the Arrangement, each former shareholder is entitled to receive $ 4.50 per Apollo share in cash (the “Consideration“). Prior to the completion of the Arrangement, the Buyer did not own any Apollo Shares.

Our partnership with Anjac will leverage Apollo’s extensive service capabilities for its global customers. Anjac’s established and exclusive credentials in personal care and over-the-counter technologies will complement Apollo’s unparalleled leadership in driving distinctive, strategic and market-first product innovations for the benefit of its dear family of clients.“- Charles Wachsberg, co-CEO of Apollo

Further details of the Arrangement are set out in Apollo’s Management Information Circular dated November 25, 2021 (the “Circular“). Registered Shareholders should send their completed and signed Letters of Transmittal and certificates representing their Apollo Shares to the Transaction Custodian, TSX Trust Company, in accordance with the instructions contained in the Letter of Transmittal as soon as possible in order to receive the consideration to which they are entitled under the arrangement. A copy of the circular and letter of transmittal can be found under Apollo’s profile at www.sedar.com.

Anjac and Apollo expect Apollo shares to be delisted from the Toronto Stock Exchange and the OTCQX market in the near future. Apollo will also apply to cease being a reporting issuer under applicable securities laws and to cease being a offering company under the OBCA.


Fasken Martineau DuMoulin LLP and Gibson Dunn & Crutcher LLP acted as Canadian and French legal counsel to Anjac, respectively, and Raymond James Ltd. acted as financial advisor to Anjac. Jeausserand Audouard and Hottinguer Corporate Finance respectively acted as French legal and financial advisor to Anjac in connection with the financing of the Arrangement.

Miller Thomson LLP and Canaccord Genuity Corp. respectively acted as Canadian legal and financial advisor to Apollo. Cassels, Brock & Blackwell LLP and Cormark Securities Inc. acted as legal counsel and financial advisor respectively to the special committee of Apollo.


Based in Toronto, Ontario, Apollo Healthcare Corp. is one of the largest manufacturers of private label personal care products in North America, developing and manufacturing branded and private label products for major North American retailers. Apollo’s products are sold in tens of thousands of stores worldwide, and its North American customer base includes major grocery, drug and mass merchandise retailers, as well as wholesale clubs. In addition to private label products, Apollo also manufactures custom products for various institutional clients on a contractual basis.


Anjac is a family-owned industrial group of health laboratories, beauty and wellness brands, which creates, develops and manufactures pharmaceuticals, medical devices and beauty products. The Anjac group of companies is made up of 13 leading and complementary companies with 21 research, development and production sites in the health, hygiene, beauty and food supplements sectors. Anjac was founded in 2008, has approximately 2,500 employees worldwide and is based in Paris, France.


This press release contains forward-looking information and statements within the meaning of applicable securities laws and is based on the expectations, estimates and projections of Apollo’s management as of the date of this press release, unless otherwise indicated. The use of any of the words “expect”, “anticipate”, “continue”, “estimate”, “objective”, “in progress”, “may”, “will”, “project”, ” should ”,“ believe ”,“ plans ”,“ intentions ”and similar expressions (including negative and grammatical variations) are intended to identify forward-looking information and statements; however, all forward-looking information and statements may not be identified by such words. In particular, this press release contains, without limitation, forward-looking information and statements regarding: the delivery of completed letters of transmittal to TSX Trust Company by registered shareholders in order to receive consideration; the timing of delisting of Apollo shares from the Toronto Stock Exchange and the OTCQX market; Apollo ceases to be a reporting issuer and an offering company. Forward-looking information and statements contained in this press release may not occur and may differ materially due to known and unknown risk factors and uncertainties. These factors include, without limitation, the risks, factors and assumptions discussed in the section titled “Risk Factors” in the Company’s Annual Information Form dated March 15, 2021 and in the section titled “Risk Factors”. in the Circular and other documents filed by the Company with the Ontario Securities Commission and other securities regulators across Canada. Although the Company has attempted to identify material factors which could cause actual actions, events or results to differ materially from those described in the forward-looking information and statements, there may be other factors that cause the actions to differ materially from those described in the forward-looking information and statements. , events or results differ from those anticipated, estimated or predicted. Readers are cautioned not to place undue reliance on any forward-looking information and statements included in this press release, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will be achieved. The forward-looking information and statements contained in this press release are made as of the date of this press release and Apollo does not undertake to publicly update or revise any forward-looking information or statements, whether as a result of de new information, future events or otherwise, except as required by applicable securities laws.


For more information, including to obtain a copy of the early warning report filed by Anjac in connection with the completion of the Arrangement (a copy of which can also be found under Apollo’s profile at www.sedar. com), please contact:

Apollo Health Corp.

[email protected]

Telephone: 416-758-3700


Source link

Comments are closed.